Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
79%
T Cells
72%
Hematopoietic Cell Transplantation
54%
Antithymocyte Globulin
38%
Graft-versus-host Disease (GvHD)
35%
Neuroblastoma
35%
Immune Reconstitution
33%
Dendritic Cells
32%
EuroFlow
31%
Metachromatic Leukodystrophy
30%
Cord Blood
29%
Pediatric
28%
Natural Killer Cells
24%
Cord Blood Transplantation
24%
Immune Monitoring
23%
High-risk Neuroblastoma
22%
Organoids
22%
MHC Class II
21%
Fludarabine
21%
Solid Tumors
21%
Immune Cells
20%
Bone Marrow
19%
Pediatric Leukemia
18%
Acute Myeloid Leukemia
18%
Immune Checkpoint Inhibitors
18%
BCP-ALL
18%
Therapeutic Drug Monitoring
17%
CD8+ T Cells
16%
Flow Cytometry
16%
Neutrophils
15%
Immune Response
15%
Cell-based
14%
CD4+ T
14%
Engineered T Cells
14%
Reconstitution
14%
CD19
13%
Immunogenicity
13%
Cell Behavior
13%
Monocytes
13%
Non-relapse Mortality
13%
Outcome Prediction
13%
T Cell Receptor
13%
Immune Recovery
13%
Gene Editing
12%
Fibrosis
12%
B Cells
12%
Hematological Malignancies
12%
Immune Landscape
12%
Acute Leukemia
12%
Automated Identification
12%
Photosystem II
12%
Minimal Residual Disease
12%
Cancer Immunotherapy
12%
In Cancer
12%
Flow Cytometric
12%
Cardiac Resynchronization Therapy
12%
Tumor
11%
Pediatric Patients
11%
Late Infantile
11%
Dendritic Cell Vaccine
11%
Vaccination
11%
Wilms Tumor
10%
Individualized Dosing
10%
Systemic Sclerosis
10%
CD4+
10%
Acute Lymphoblastic Leukemia
10%
Leukemia Patients
10%
T Cell Activation
9%
Cell Therapy
9%
Hemophagocytic Lymphohistiocytosis
9%
Graft Failure
9%
Adult Patients
9%
Immune Parameters
9%
Immunoblot Analysis
9%
Dutch
9%
Anti-GD2
8%
Single-cell RNA Sequencing (scRNA-seq)
8%
Adoptive Cell Therapy
8%
Anti-PD-1
8%
Tumor Cells
8%
Overall Survival
8%
Disease Progression
8%
Confidence Interval
8%
T Cell Response
8%
Multidimensional Analysis
8%
High Risk
8%
Cellular Immunotherapy
8%
Recombinant
7%
Cancer Therapy
7%
Clofarabine
7%
Mode of Action
7%
Working Diagnosis
7%
Clinical Trials
7%
CD115
7%
Regulatory T Cells
7%
Relapsed or Refractory Acute Myeloid Leukemia
7%
CD34+ Cells
7%
Killing Assay
7%
Peripheral Blood
7%
Drug Library Screening
7%
Immunology and Microbiology
T Cell
100%
Hematopoietic Cell
81%
Cell Transplantation
68%
Immunity
60%
Immune Reconstitution
46%
Immunotherapy
43%
Myeloid
40%
Precursor
39%
B Cell
34%
Anti-Thymocyte Globulin
31%
Organoid
29%
Immunocompetent Cell
27%
Dendritic Cell
26%
Immunology
25%
Cord Blood Stem Cell Transplantation
23%
Graft-Versus-Host Disease
22%
Natural Killer Cell
22%
COVID-19
18%
T-Helper Cell
15%
Systemic Scleroderma
15%
Immune Response
15%
Cell Function
14%
CD4
14%
T Cell Receptor
14%
Immunogenicity
14%
Hematopoietic Stem Cell Transplantation
13%
Neutrophil Granulocyte
13%
Acute Graft Versus Host Disease
12%
Cardiac Resynchronization Therapy
12%
Cancer Immunotherapy
12%
CD19
12%
Dendritic Cell Vaccine
11%
CD3 Antigen
11%
Major Histocompatibility Complex
11%
Hemophagocytic Lymphohistiocytosis
10%
Coculture
10%
CD34
10%
Neutrophil
9%
Cytotoxic T-Cell
9%
Cytotoxicity
9%
Tumor Cell
9%
Stem Cell
9%
Dynamics
9%
RNA Sequence
9%
interferon
8%
Blood Plasma
8%
Immunoglobulin A
8%
Allogeneic Hematopoietic Stem Cell Transplantation
8%
Blood Level
8%
Overall Survival
7%
Cell Lineage
7%
Leukocyte
7%
Adherent Cell
6%
Decision Making
6%
Conditioning
6%
Drug Megadose
6%
Chimeric Antigen Receptor T-Cell
6%
CD14
6%
Regulatory T Cell
6%
Tertiary Lymphoid Structure
6%
Colitis
6%
Immune Landscape
6%
Arm
6%
Complement Component C1q
6%
Immune-Mediated Inflammatory Diseases
6%
Collagen Degradation
6%
Leporidae
6%
MHC Class I
6%
Thymocyte
6%
Naive T Cell
6%
Inflammatory Arthritis
6%
Adenosine Deaminase
6%
Arthritis
6%
Reference Database
6%
Myofibroblast
6%
Liquid Chromatography Tandem Mass Spectrometry
6%
Systemic Inflammation
6%
Dermatomyositis
6%
Neurofilament
6%
Stroma
6%
Downregulation
6%
Staining
6%
Light Chain
6%
Primary Immunodeficiency
6%
Ecalectin
6%
Autologous Hematopoietic Stem Cell Transplantation
6%
Central Nervous System
6%
Allogeneic Stem Cell Transplantation
6%
CRISPR/Cas9
6%
Death Receptor
6%
P53
6%
Extracellular Matrix
5%
Mouse Model
5%
Bone Marrow Transplantation
5%
Common Variable Immunodeficiency
5%
Medicine and Dentistry
T Cell
51%
Hematopoietic Cell
49%
Cell Transplantation
43%
Immunity
36%
Immunotherapy
32%
Ganglioneuroblastoma
31%
Metachromatic Leukodystrophy
24%
Acute Myeloid Leukemia
22%
Cord Blood
20%
Dendritic Cell
20%
Pediatric Acute Myeloid Leukemia
18%
B Cell
18%
Precursor
18%
Immune Reconstitution
18%
Cord Blood Stem Cell Transplantation
18%
Pediatrics
17%
T Lymphocyte Receptor
16%
Organoid
15%
Immunocompetent Cell
15%
Neutrophil
14%
Neoplasm
14%
Disease
13%
Solid Malignant Neoplasm
13%
Natural Killer Cell
13%
Acute Lymphoblastic Leukemia
12%
Clustered Regularly Interspaced Short Palindromic Repeat
12%
Graft Versus Host Reaction
11%
Cell Therapy
10%
Flow Cytometry
10%
Dendritic Cell Vaccine
10%
Clinical Trial
10%
Wilms' Tumor
9%
Hematologic Malignancy
8%
Cytotoxic T-Cell
8%
Cancer
8%
Stroma
7%
Interferon
7%
Diagnosis
7%
Transplantation
7%
Central Nervous System
7%
Leukocyte
7%
RNA Sequence
7%
T-Helper Cell
6%
Clinical Feature
6%
Immunogenicity
6%
Adherent Cell
6%
Minimal Residual Disease
6%
Fludarabine
6%
Glial Fibrillary Acidic Protein
6%
Childhood Cancer
6%
Fusion Gene
6%
Cardiac Resynchronization Therapy
6%
Dermatomyositis
6%
Interferon Induced Helicase C Domain Containing Protein 1
6%
Meta-Analysis
6%
Targeted Therapy
6%
Light Chain
6%
Nicotinamide
6%
Immune Dysregulation
6%
Tertiary Lymphoid Structure
6%
Paralytic Strabismus
6%
CRISPR Associated Protein
6%
Neurofilament
6%
Systematic Review
6%
Hematopoietic Stem Cell Transplantation
6%
Regulatory T Cell
6%
Mucopolysaccharidosis
6%
Graft Versus Leukemia Effect
6%
Acute Leukemia
6%
Disease Modifying Therapy
6%
Disease Assessment
6%
Cell Lineage
6%
Immunoglobulin A
6%
Polyneuropathy
6%
Interstitial Lung Disease
6%
Tumor Cell
6%
Cas9
6%
Pulmonary Embolism
6%
Acute Megakaryoblastic Leukemia
6%
Protein Analysis
6%
COVID-19
6%
Congestive Heart Failure
6%
In Vitro
5%
T Cell Receptor
5%
Bone Marrow Transplantation
5%